Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged.
| Autor: | Werner GS; Klinikum Darmstadt GmbH, Darmstadt, Germany., Hildick-Smith D; Sussex Cardiac Centre, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom., Trial Investigators FTE |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2024 Jan 01; Vol. 20 (1), pp. 110. |
| DOI: | 10.4244/EIJ-D-23-00857 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|